Diego Geroldi Selected Research

Apoprotein(a) (Apolipoprotein (a))

4/2005	Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
12/2004	Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
8/2004	Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women.
2/2004	Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.
2/2004	Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
1/2004	Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia.
12/2003	Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans.
12/2003	Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.
8/2002	Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diego Geroldi Research Topics

Disease

6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2010 - 08/2002
6	Alzheimer Disease (Alzheimer's Disease) 01/2006 - 01/2004
5	Atherosclerosis 04/2008 - 02/2005
3	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 11/2005 - 01/2004
3	Coronary Disease (Coronary Heart Disease) 06/2004 - 12/2003
2	Hypertension (High Blood Pressure) 01/2010 - 04/2006
2	Acute Coronary Syndrome 01/2007 - 12/2004
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2005 - 01/2004
2	Dementia (Dementias) 06/2004 - 01/2004
1	Chronic Hepatitis C 02/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Inflammation (Inflammations) 01/2010
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2010
1	Hypochondriasis 11/2008
1	Mania (Manias) 12/2007
1	Hypercholesterolemia 11/2007
1	Familial Mediterranean Fever (Periodic Disease) 01/2007
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2007
1	Myocardial Infarction 08/2006
1	Stable Angina 04/2006
1	Neoplasms (Cancer) 01/2006
1	Schizophrenia (Dementia Praecox) 01/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2006
1	Vascular Diseases (Vascular Disease) 11/2005
1	Diabetic Angiopathies (Diabetic Angiopathy) 11/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2005
1	Essential Hypertension 09/2005
1	Mental Disorders (Mental Disorder) 09/2005
1	Hyperaldosteronism (Conn Syndrome) 09/2005
1	Vascular System Injuries 09/2005
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2005
1	Obesity 08/2004
1	Thrombosis (Thrombus) 03/2004
1	Ischemia 02/2004
1	Stroke (Strokes) 01/2004
1	Frontotemporal Dementia (Semantic Dementia) 12/2003
1	Overweight 12/2003
1	Type 2 Diabetes Mellitus (MODY) 05/2003

Drug/Important Bio-Agent (IBA)

9	Apoprotein(a) (Apolipoprotein (a))IBA 04/2005 - 08/2002
7	Protein Isoforms (Isoforms)IBA 11/2005 - 12/2003
7	Apolipoproteins AIBA 12/2004 - 05/2003
6	Receptor for Advanced Glycation End ProductsIBA 01/2010 - 04/2005
5	Lipoprotein(a)IBA 02/2005 - 08/2002
4	Biomarkers (Surrogate Marker)IBA 01/2010 - 02/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2010 - 04/2006
2	Matrix Metalloproteinases (MMPs)IBA 01/2007 - 11/2005
2	Cell Surface ReceptorsIBA 11/2005 - 05/2005
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2005 - 01/2004
2	Glycoproteins (Glycoprotein)IBA 10/2005 - 02/2004
1	Metformin (Glucophage)FDA LinkGeneric 02/2010
1	proanthocyanidinIBA 01/2010
1	Cardiovascular AgentsIBA 01/2010
1	ThiazolidinedionesIBA 01/2010
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2010
1	LigandsIBA 01/2010
1	Serotonin (5 Hydroxytryptamine)IBA 11/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2007
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2007
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2007
1	Serotonin ReceptorsIBA 12/2007
1	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 12/2007
1	Atorvastatin (Lipitor)FDA Link 11/2007
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2007
1	Metalloproteases (Metalloproteinases)IBA 01/2007
1	PyrinIBA 01/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2007
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 08/2006
1	ChemokinesIBA 05/2006
1	OsteopontinIBA 04/2006
1	C-Reactive ProteinIBA 04/2006
1	Toll-Like Receptor 4IBA 01/2006
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2006
1	Chemokine ReceptorsIBA 01/2006
1	AcetylcholinesteraseIBA 01/2006
1	alpha-2-HS-GlycoproteinIBA 10/2005
1	Biological ProductsIBA 10/2005
1	ReninIBA 09/2005
1	AldosteroneIBA 09/2005
1	OsteoprotegerinIBA 06/2004
1	CytokinesIBA 06/2004
1	Genetic Markers (Genetic Marker)IBA 03/2004
1	Lipoproteins (Lipoprotein)IBA 01/2004
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2004

Therapy/Procedure

1	Therapeutics 01/2010
1	Renal Dialysis (Hemodialysis) 03/2004